Kurs
+3,33%
Likviditet
0,01 MSEK
Prenumeration
Kalender
Tid* | ||
2026-02-25 | 08:00 | Bokslutskommuniké 2025 |
2025-11-12 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-13 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-14 | N/A | Årsstämma |
2025-05-14 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-26 | 08:00 | Bokslutskommuniké 2024 |
2025-01-20 | - | Extra Bolagsstämma 2025 |
2024-11-13 | - | Kvartalsrapport 2024-Q3 |
2024-08-14 | - | Kvartalsrapport 2024-Q2 |
2024-05-30 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2024-05-29 | - | Årsstämma |
2024-05-15 | - | Kvartalsrapport 2024-Q1 |
2024-04-05 | - | Extra Bolagsstämma 2024 |
2024-02-28 | - | Bokslutskommuniké 2023 |
2023-12-20 | - | Extra Bolagsstämma 2023 |
2023-11-08 | - | Kvartalsrapport 2023-Q3 |
2023-07-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-29 | - | Årsstämma |
2023-05-16 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2023-05-08 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-17 | - | Kvartalsrapport 2022-Q2 |
2022-05-16 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2022-05-13 | - | Årsstämma |
2022-05-13 | - | Kvartalsrapport 2022-Q1 |
2022-04-08 | - | Extra Bolagsstämma 2022 |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-11-10 | - | Kvartalsrapport 2021-Q3 |
2021-08-18 | - | Kvartalsrapport 2021-Q2 |
2021-05-10 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2021-05-07 | - | Årsstämma |
2021-05-07 | - | Kvartalsrapport 2021-Q1 |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-11-10 | - | Kvartalsrapport 2020-Q3 |
2020-08-18 | - | Kvartalsrapport 2020-Q2 |
2020-06-05 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2020-06-04 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-12-19 | - | Extra Bolagsstämma 2019 |
2019-11-05 | - | Kvartalsrapport 2019-Q3 |
2019-08-13 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2019-05-08 | - | Årsstämma |
2019-05-08 | - | Kvartalsrapport 2019-Q1 |
2019-02-12 | - | Bokslutskommuniké 2018 |
2018-11-20 | - | Kvartalsrapport 2018-Q3 |
2018-08-21 | - | Kvartalsrapport 2018-Q2 |
2018-07-25 | - | Extra Bolagsstämma 2018 |
2018-05-09 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2018-05-08 | - | Årsstämma |
2018-05-08 | - | Kvartalsrapport 2018-Q1 |
2018-02-20 | - | Bokslutskommuniké 2017 |
2017-11-21 | - | Kvartalsrapport 2017-Q3 |
2017-08-22 | - | Kvartalsrapport 2017-Q2 |
2017-05-11 | - | Årsstämma |
2017-05-11 | - | Kvartalsrapport 2017-Q1 |
2017-04-22 | - | Bokslutskommuniké 2016 |
2016-11-11 | - | Kvartalsrapport 2016-Q3 |
2016-09-21 | - | Extra Bolagsstämma 2016 |
2016-08-24 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Handel & varor |
Industri | Dagligvaror |
Simris Group AB (publ), reg. no. 556841–9187 (the "Company") held an extraordinary general meeting on 20 January 2025. Below follows a summary of the resolutions that were passed at the meeting.
Resolution on entering into loan agreements
The general meeting resolved to enter into loan agreements with Frank Puccio amounting to EUR 50,000, Royce CoLabs AB, a company controlled by Jonathan Royce, amounting to EUR 10,000, Magnus Högström amounting to EUR 30,000, Arminnovate Ltd, a company controlled by Dr Alexis Roberts-McIntosh, Amounting to EUR 20,000 and Christoffer Tell AB, a company controlled by Christoffer Tell amounting to EUR 30,000 for a total loan amount of EUR 140,000 and to instruct the board of directors to execute the loan agreements (“Loan Agreements”).
The Loan Agreements shall have a monthly interest rate of one (1) per cent and a maturity date of 31 December 2025. The lenders shall have a right to convert all outstanding loan and interest to B-shares at a subscription price of SEK 0.05 per B-share. If the Company conducts a capital raise before 31 December 2025 the subscription price shall be lowered to correspond with the subscription price in such capital raise.
The board of directors submitted the Loan Agreements to the general meeting for approval due to conflict of interests of its members according to the Swedish Companies Act.
Contact Details:
Dr Alexis Roberts-McIntosh
CEO Simris Group AB
Email: ir@simris.com
Mobile: +44 (0) 7940 585298
www.simrisgroup.com
About Simris Group AB (PUBL):
Simris Group is a biologics company identifying and commercialising high value, natural, biologically active compounds found in microalgae and cyanobacteria to extract for applications in biopharmaceuticals, dietary supplements and cosmetics.
Simris Group's shares are traded on the Nasdaq First North Growth Market with the short name SIMRIS and ISIN code SE0008091664.
Certified Adviser is Amudova AB, telephone: 08-546 017 58, email: info@amudova.se.